HAMP and chronic kidney disease: Some studies have shown the association of hepcidin-25 with increased CV mortality risk in HD patients (15) or with all-cause mortality in diabetic CKD patients (30), while Eisenga et al. have not found a predictive role of hepcidin-25 in mortality among patients with kidney transplantation (31).